anti-angiogenesis and mtor inhibition in carcinoid tumors
Published 8 years ago • 289 plays • Length 5:02Download video MP4
Download video MP3
Similar videos
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
5:30
using combination therapies in advanced pnets
-
1:39
dr. rugo on anti-angiogenesis therapy response predictors
-
7:36
angiogenesis in tumor growth and metastasis
-
4:27
treatments against tumor angiogenesis
-
3:19
carcinoid syndrome in patients with nets
-
0:51
dr. mcdonald talks about the next step for angiogenesis inhibitors
-
5:43
managing mtor inhibitor induced adverse events
-
4:39
using sunitinib in pancreatic neuroendocrine tumors (pnets)
-
4:50
tumor angiogenesis
-
9:15
the potential for combination therapy in neuroendocrine tumors
-
1:58
anti-angiogenesis drugs, part iv
-
10:12
angiogenesis
-
1:10:02
tumor microenvironment 2 and angiogenesis
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
1:03
three-dimensional retinal organoids facilitate the investigation of retinal ganglion cell
-
8:05
anti-angiogenesis drugs, part ii
-
23:57
a comparison of angiogenesis inhibitor trial designs and outcomes in mcrc
-
7:29
ecc 2015: radiant-4 trial showed promise in the treatment of neuroendocrine tumours